SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-16-007294
Filing Date
2016-05-10
Accepted
2016-05-10 16:11:56
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tenx_10q.htm 10-Q 580626
2 CERTIFICATION tenx_ex311.htm EX-31.1 13657
3 CERTIFICATION tenx_ex312.htm EX-31.2 13666
4 CERTIFICATION tenx_ex321.htm EX-32.1 6640
5 CERTIFICATION tenx_ex322.htm EX-32.2 7718
  Complete submission text file 0001354488-16-007294.txt   2496922

Data Files

Seq Description Document Type Size
6 tenx-20160331.xml EX-101.INS 494191
7 tenx-20160331.xsd EX-101.SCH 23886
8 tenx-20160331_cal.xml EX-101.CAL 34230
9 tenx-20160331_def.xml EX-101.DEF 32693
10 tenx-20160331_lab.xml EX-101.LAB 177151
11 tenx-20160331_pre.xml EX-101.PRE 123665
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34600 | Film No.: 161635893
SIC: 8731 Services-Commercial Physical & Biological Research